UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 8, 2020
Accession Number:
0001493152-20-010348
Submission Type:
POS AM
CIK:
0001528172
Company Name:
ENDONOVO THERAPEUTICS, INC.
File Number:
333-229146